Cargando…
Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression
BACKGROUND: Bufei Yishen formula (BYF) is an effective prescription for the clinical treatment of chronic obstructive pulmonary disease (COPD). However, the molecular mechanism by which it exerts its pharmacological effects remains to be explored. METHODS: The human bronchial cell line BEAS-2B was t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094478/ https://www.ncbi.nlm.nih.gov/pubmed/37065635 http://dx.doi.org/10.2147/COPD.S383295 |
_version_ | 1785023851500929024 |
---|---|
author | Wang, Weimin Zhang, Shaohong Cui, Lei Chen, Yu Xu, Xingxing Wu, Longchuan |
author_facet | Wang, Weimin Zhang, Shaohong Cui, Lei Chen, Yu Xu, Xingxing Wu, Longchuan |
author_sort | Wang, Weimin |
collection | PubMed |
description | BACKGROUND: Bufei Yishen formula (BYF) is an effective prescription for the clinical treatment of chronic obstructive pulmonary disease (COPD). However, the molecular mechanism by which it exerts its pharmacological effects remains to be explored. METHODS: The human bronchial cell line BEAS-2B was treated with cigarette smoke extract (CSE). Cellular senescence markers were detected by Western blot and ELISA. Potential transcription factor of klotho was predicted using JASPAR and USCS databases. RESULTS: CSE induced cellular senescence with intracellular accumulation of cellular senescence biomarkers (p16, p21 and p27) and increased secretion of senescence-related secretory phenotypic (SASP) factors (IL-6, IL-8, and CCL3). In contrast, BYF treatment inhibited CSE-induced cellular senescence. CSE suppressed the transcription, expression and secretion of klotho, whereas BYF treatment rescued its transcription, expression and secretion. CSE downregulated the protein level of ZNF263, whereas BYF treatment rescued the expression of ZNF263. Furthermore, ZNF263-overexpressing BEAS-2B cells could inhibit CSE-induced cellular senescence and SASP factor secretion by upregulating the expression of klotho. CONCLUSION: This study revealed a novel pharmacological mechanism by which BYF alleviates clinical symptoms of COPD patients, and regulating ZNF263 and klotho expression may be beneficial to the treatment and prevention of COPD. |
format | Online Article Text |
id | pubmed-10094478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-100944782023-04-13 Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression Wang, Weimin Zhang, Shaohong Cui, Lei Chen, Yu Xu, Xingxing Wu, Longchuan Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Bufei Yishen formula (BYF) is an effective prescription for the clinical treatment of chronic obstructive pulmonary disease (COPD). However, the molecular mechanism by which it exerts its pharmacological effects remains to be explored. METHODS: The human bronchial cell line BEAS-2B was treated with cigarette smoke extract (CSE). Cellular senescence markers were detected by Western blot and ELISA. Potential transcription factor of klotho was predicted using JASPAR and USCS databases. RESULTS: CSE induced cellular senescence with intracellular accumulation of cellular senescence biomarkers (p16, p21 and p27) and increased secretion of senescence-related secretory phenotypic (SASP) factors (IL-6, IL-8, and CCL3). In contrast, BYF treatment inhibited CSE-induced cellular senescence. CSE suppressed the transcription, expression and secretion of klotho, whereas BYF treatment rescued its transcription, expression and secretion. CSE downregulated the protein level of ZNF263, whereas BYF treatment rescued the expression of ZNF263. Furthermore, ZNF263-overexpressing BEAS-2B cells could inhibit CSE-induced cellular senescence and SASP factor secretion by upregulating the expression of klotho. CONCLUSION: This study revealed a novel pharmacological mechanism by which BYF alleviates clinical symptoms of COPD patients, and regulating ZNF263 and klotho expression may be beneficial to the treatment and prevention of COPD. Dove 2023-04-08 /pmc/articles/PMC10094478/ /pubmed/37065635 http://dx.doi.org/10.2147/COPD.S383295 Text en © 2023 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wang, Weimin Zhang, Shaohong Cui, Lei Chen, Yu Xu, Xingxing Wu, Longchuan Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression |
title | Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression |
title_full | Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression |
title_fullStr | Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression |
title_full_unstemmed | Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression |
title_short | Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression |
title_sort | bufei yishen formula inhibits the cell senescence in copd by up-regulating the znf263 and klotho expression |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094478/ https://www.ncbi.nlm.nih.gov/pubmed/37065635 http://dx.doi.org/10.2147/COPD.S383295 |
work_keys_str_mv | AT wangweimin bufeiyishenformulainhibitsthecellsenescenceincopdbyupregulatingtheznf263andklothoexpression AT zhangshaohong bufeiyishenformulainhibitsthecellsenescenceincopdbyupregulatingtheznf263andklothoexpression AT cuilei bufeiyishenformulainhibitsthecellsenescenceincopdbyupregulatingtheznf263andklothoexpression AT chenyu bufeiyishenformulainhibitsthecellsenescenceincopdbyupregulatingtheznf263andklothoexpression AT xuxingxing bufeiyishenformulainhibitsthecellsenescenceincopdbyupregulatingtheznf263andklothoexpression AT wulongchuan bufeiyishenformulainhibitsthecellsenescenceincopdbyupregulatingtheznf263andklothoexpression |